Benjamin Lopez Selected Research

(5,6,7,8- tetrahydronaphthalen- 1- yl)- (2- (1H- tetrazol- 5- yl)phenyl)amine

1/2023	Activation of TREK-1 (K2P2.1) potassium channels protects against influenza A-induced lung injury.
12/2020	K2P2.1 (TREK-1) potassium channel activation protects against hyperoxia-induced lung injury.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Benjamin Lopez Research Topics

Disease

5	Hyperoxia 01/2021 - 05/2011
4	Infections 01/2023 - 03/2015
3	Acute Lung Injury 01/2023 - 12/2020
3	Lung Injury 01/2023 - 12/2017
3	Systemic Scleroderma (Systemic Sclerosis) 01/2021 - 01/2018
2	Inflammation (Inflammations) 02/2023 - 03/2014
2	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 01/2023 - 03/2015
2	Bacterial Infections (Bacterial Infection) 01/2023 - 07/2017
2	Pneumonia (Pneumonitis) 01/2023 - 03/2015
2	Interstitial Lung Diseases (Interstitial Lung Disease) 01/2021 - 01/2021
2	Amyloidosis 01/2021 - 01/2018
1	Human Influenza (Influenza) 01/2023
1	Atypical Hemolytic Uremic Syndrome 01/2023
1	Hemolysis 01/2023
1	Thrombotic Microangiopathies 01/2023
1	Antisynthetase syndrome 01/2021
1	Connective Tissue Diseases (Connective Tissue Disease) 01/2021
1	Myositis (Idiopathic Inflammatory Myopathies) 01/2021
1	Neoplasms (Cancer) 01/2021
1	Eosinophilia 01/2020
1	Hyperplasia 01/2020
1	Asthma (Bronchial Asthma) 01/2020
1	Immunoglobulin G4-Related Disease 01/2020
1	Lymphadenopathy 01/2020
1	Hemophilia A (Haemophilia) 01/2020
1	Vasculitis (Vasculitides) 01/2020
1	Fibrosis (Cirrhosis) 10/2019
1	Hepatocellular Carcinoma (Hepatoma) 09/2019
1	Hypereosinophilic Syndrome (Loeffler Endocarditis) 04/2019
1	Churg-Strauss Syndrome (Allergic Angiitis) 04/2019
1	Meretoja syndrome 01/2018
1	Dengue (Dengue Fever) 01/2017
1	Embolism (Embolus) 12/2016
1	Thrombosis (Thrombus) 12/2016
1	Aortic Aneurysm (Aneurysm, Aortic) 12/2016
1	Aneurysm (Aneurysms) 12/2016
1	Cysts 07/2015
1	Lung Diseases (Lung Disease) 03/2014
1	Apnea 03/2014
1	Respiratory Insufficiency (Respiratory Failure) 06/2011
1	Emphysema 05/2011

Drug/Important Bio-Agent (IBA)

4	Proteins (Proteins, Gene)FDA Link 01/2023 - 12/2017
4	potassium channel protein TREK-1IBA 01/2023 - 12/2017
3	Interleukin-6 (Interleukin 6)IBA 02/2023 - 12/2020
3	Potassium Channels (Potassium Channel)IBA 02/2023 - 12/2020
3	AntibodiesIBA 01/2021 - 01/2020
2	SPADIBA 01/2023 - 07/2017
2	(5,6,7,8- tetrahydronaphthalen- 1- yl)- (2- (1H- tetrazol- 5- yl)phenyl)amineIBA 01/2023 - 12/2020
2	Polysaccharides (Glycans)IBA 01/2023 - 07/2017
2	Amyloid (Amyloid Fibrils)IBA 01/2021 - 01/2018
2	CytokinesIBA 01/2021 - 12/2017
2	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 01/2020 - 04/2019
1	Peptides (Polypeptides)IBA 01/2023
1	Protons (Proton)IBA 01/2023
1	heme aIBA 01/2023
1	Complement System Proteins (Complement)IBA 01/2023
1	Heparitin Sulfate (Heparan Sulfate)IBA 01/2023
1	Formaldehyde (Formol)FDA Link 01/2021
1	ParaffinIBA 01/2021
1	Biomarkers (Surrogate Marker)IBA 01/2021
1	Large-Conductance Calcium-Activated Potassium Channels (Maxi-K Channels)IBA 01/2021
1	Immunoglobulin G (IgG)IBA 01/2020
1	AutoantibodiesIBA 01/2020
1	Factor VIII (Coagulation Factor VIII)IBA 01/2020
1	Caveolin 1IBA 10/2019
1	C-Reactive ProteinIBA 04/2019
1	Antiphospholipid AntibodiesIBA 01/2018
1	poractant alfa (Curosurf)FDA Link 12/2017
1	PotassiumIBA 12/2017
1	Surface-Active Agents (Surfactants)IBA 12/2017
1	Immunoglobulins (Immunoglobulin)IBA 07/2017
1	T-Lymphocyte Epitopes (Epitopes, T Lymphocyte)IBA 01/2017
1	Attenuated VaccinesIBA 01/2017
1	Doxycycline (Periostat)FDA LinkGeneric 07/2015
1	EndotoxinsIBA 03/2015
1	Adenosine (Adenocard)FDA LinkGeneric 03/2014
1	Caffeine (No Doz)FDA LinkGeneric 03/2014
1	Purinergic P1 Receptor AntagonistsIBA 03/2014
1	Ganciclovir (Cytovene)FDA LinkGeneric 06/2011
1	Histone Deacetylases (Histone Deacetylase)IBA 05/2011
1	Cyclin-Dependent Kinase Inhibitor p21IBA 05/2011

Therapy/Procedure

3	Therapeutics 01/2023 - 07/2017
1	Injections 12/2020
1	Lymph Node Excision (Lymph Node Dissection) 01/2020
1	Microspheres (Microsphere) 09/2019
1	Stents 12/2016
1	Endovascular Aneurysm Repair 12/2016
1	Artificial Respiration (Mechanical Ventilation) 07/2015